Literature DB >> 33613459

Direct Evidence of Abortive Lytic Infection-Mediated Establishment of Epstein-Barr Virus Latency During B-Cell Infection.

Tomoki Inagaki1, Yoshitaka Sato1,2, Jumpei Ito3, Mitsuaki Takaki4, Yusuke Okuno5, Masahiro Yaguchi1, H M Abdullah Al Masud1,6, Takahiro Watanabe1, Kei Sato3, Shingo Iwami4,7,8, Takayuki Murata1,9, Hiroshi Kimura1.   

Abstract

Viral infection induces dynamic changes in transcriptional profiles. Virus-induced and antiviral responses are intertwined during the infection. Epstein-Barr virus (EBV) is a human gammaherpesvirus that provides a model of herpesvirus latency. To measure the transcriptome changes during the establishment of EBV latency, we infected EBV-negative Akata cells with EBV-EGFP and performed transcriptome sequencing (RNA-seq) at 0, 2, 4, 7, 10, and 14 days after infection. We found transient downregulation of mitotic division-related genes, reflecting reprogramming of cell growth by EBV, and a burst of viral lytic gene expression in the early phase of infection. Experimental and mathematical investigations demonstrate that infectious virions were not produced in the pre-latent phase, suggesting the presence of an abortive lytic infection. Fate mapping using recombinant EBV provided direct evidence that the abortive lytic infection in the pre-latent phase converges to latent infection during EBV infection of B-cells, shedding light on novel roles of viral lytic gene(s) in establishing latency. Furthermore, we find that the BZLF1 protein, which is a key regulator of reactivation, was dispensable for abortive lytic infection in the pre-latent phase, suggesting the divergent regulation of viral gene expressions from a productive lytic infection.
Copyright © 2021 Inagaki, Sato, Ito, Takaki, Okuno, Yaguchi, Masud, Watanabe, Sato, Iwami, Murata and Kimura.

Entities:  

Keywords:  EBV; abortive lytic infection; fate mapping; neo virology; pre-latent phase

Year:  2021        PMID: 33613459      PMCID: PMC7888302          DOI: 10.3389/fmicb.2020.575255

Source DB:  PubMed          Journal:  Front Microbiol        ISSN: 1664-302X            Impact factor:   5.640


  7 in total

Review 1.  Cancers associated with human gammaherpesviruses.

Authors:  Kwun Wah Wen; Linlin Wang; Joshua R Menke; Blossom Damania
Journal:  FEBS J       Date:  2021-09-18       Impact factor: 5.622

2.  Detection and characterization of latency stage of EBV and histopathological analysis of prostatic adenocarcinoma tissues.

Authors:  Khalid Ahmed; Alisalman Sheikh; Saira Fatima; Ghulam Haider; Kulsoom Ghias; Farhat Abbas; Nouman Mughal; Syed Hani Abidi
Journal:  Sci Rep       Date:  2022-06-21       Impact factor: 4.996

3.  Epstein-Barr virus tegument protein BGLF2 in exosomes released from virus-producing cells facilitates de novo infection.

Authors:  Yoshitaka Sato; Masahiro Yaguchi; Yusuke Okuno; Hanako Ishimaru; Ken Sagou; Somi Ozaki; Takeshi Suzuki; Tomoki Inagaki; Miki Umeda; Takahiro Watanabe; Masahiro Fujimuro; Takayuki Murata; Hiroshi Kimura
Journal:  Cell Commun Signal       Date:  2022-06-21       Impact factor: 7.525

Review 4.  Replication Compartments-The Great Survival Strategy for Epstein-Barr Virus Lytic Replication.

Authors:  Atsuko Sugimoto
Journal:  Microorganisms       Date:  2022-04-25

Review 5.  Molecular Basis of Epstein-Barr Virus Latency Establishment and Lytic Reactivation.

Authors:  Takayuki Murata; Atsuko Sugimoto; Tomoki Inagaki; Yusuke Yanagi; Takahiro Watanabe; Yoshitaka Sato; Hiroshi Kimura
Journal:  Viruses       Date:  2021-11-23       Impact factor: 5.048

6.  Resurrecting Epstein-Barr Virus.

Authors:  Roberto Paganelli
Journal:  Pathogens       Date:  2022-07-06

Review 7.  Roles of Lytic Viral Replication and Co-Infections in the Oncogenesis and Immune Control of the Epstein-Barr Virus.

Authors:  Yun Deng; Christian Münz
Journal:  Cancers (Basel)       Date:  2021-05-10       Impact factor: 6.639

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.